Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Facebook Inc. (NASDAQ:FB), which closed its acquisition of mobile messaging service WhatsApp on Monday, has no near-term plan to make money from the service, Chief Executive Mark Zuckerberg said on Thursday. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70% and weekly performance is -5.85%. On last trading day company shares ended up $72.91. Facebook Inc (NASDAQ:FB) distance from 50-day simple … Continue reading Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Jayne Crisman10/1310/13

Today’s Watch List : Nabors Industries (NYSE:NBR), Wells Fargo & Company (NYSE:WFC), Progenics Pharmaceuticals (NASDAQ:PGNX), Recro Pharma (NASDAQ:REPH), Masco Corporation (NYSE:MAS),

Nabors Industries (NYSE:NBR) has been given a “BBB-” credit rating by Morningstar. The credit rating agency’s “BBB-” rating suggests that the company is a moderate default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating. Nabors Industries Ltd. (NYSE:NBR) belongs to Basic Materials sector. Its net profit margin is 2.40% and weekly performance is 0.12%. … Continue reading Today’s Watch List : Nabors Industries (NYSE:NBR), Wells Fargo & Company (NYSE:WFC), Progenics Pharmaceuticals (NASDAQ:PGNX), Recro Pharma (NASDAQ:REPH), Masco Corporation (NYSE:MAS),

Colin Pettis09/1709/17

Whats Hot Today: Verizon Communications Inc. (NYSE:VZ), Recro Pharma, Inc. (NASDAQ:REPH), Symantec Corporation (NASDAQ:SYMC), USEC Inc. (NYSE:USU), Enbridge Inc. (NYSE:ENB)

CNBC’s Jon Fortt talked to Dan Mead, Verizon Wireless President & CEO in a program about Verizon Communications Inc. (NYSE:VZ)’s expectations from Apple Inc. (NASDAQ:AAPL) and future business plans. Mead said that Apple Inc. (NASDAQ:AAPL) is a very important business partner of Verizon in the industry and he is extremely excited about the product launch event of Apple Inc. (NASDAQ:AAPL) today.Verizon Communications Inc. (NYSE:VZ) belongs … Continue reading Whats Hot Today: Verizon Communications Inc. (NYSE:VZ), Recro Pharma, Inc. (NASDAQ:REPH), Symantec Corporation (NASDAQ:SYMC), USEC Inc. (NYSE:USU), Enbridge Inc. (NYSE:ENB)

Ryan Holtz09/1209/12

Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Aegis started coverage on shares of Recro Pharma Inc. (NASDAQ:REPH) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $40.00 price target on the stock. Aegis’ price objective suggests a potential upside of 412.16% from the company’s current price. Recro Pharma Inc (NASDAQ:REPH) stock performance was -7.30% in last session and finished the day at $7.24. Traded … Continue reading Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Mark Doerr06/1706/17

Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

BMO Capital Markets boosted their price target on shares of Applied Genetic Technologies Corp (NASDAQ:AGTC) from $21.00 to $34.00 in a research note issued on Monday. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price points to a potential upside of 34.44% from the stock’s previous close. Applied Genetic Technologies Corp (NASDAQ:AGTC) stock performance was 7.57% in last session … Continue reading Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

Kristen Barton06/1306/13

Healthcare Decliners: SunLink Health Systems, Inc. (NYSEMKT:SSY), Recro Pharma Inc (NASDAQ:REPH), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Retrophin Inc (NASDAQ:RTRX)

SunLink Health Systems Inc. (NYSEMKT:SSY) said that net loss for the third-quarter ended March 31, 2014 widened to $964,000 or $0.10 per share, from $186,000 or $0.02 per share last year. Loss from continuing operations for the quarter was $911,000 or $0.10 per share, compared to a loss from continuing operations of $197,000 or $0.02 per share in the prior year. Quarterly operating loss from … Continue reading Healthcare Decliners: SunLink Health Systems, Inc. (NYSEMKT:SSY), Recro Pharma Inc (NASDAQ:REPH), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Retrophin Inc (NASDAQ:RTRX)

Richard Atkins05/3005/30